The National Association of Pharmaceutical Manufacturers (NAPM) was established in 1977 as A Section 21 Trade Association which. It is a voluntary, non-profit organisation consisting of South African and Generics based Pharmaceutical manufacturers and distributors. The NAPM has a diverse membership comprising of 18 companies. Part of the NAPM’s function is to ensure that the sector plays a constructive role in our country’s economic growth, development and transformation and thereby create an environment in which the sector can thrive, expand, be competitive and enhance access of medicines to all of our country’s citizens.
NAPM supports Government’s objectives of
- Increasing life expectancy of South Africans
- Decreasing maternal and child mortality
- Combatting HIV / Aids , TB and Non-communicable diseases
- Strengthening health system effectiveness.
NAPM is a founder member of The Southern African Generics Manufacturers Association (SAGMA) and an Exco member of the International Generics Pharmaceutical Alliance (IGPA).
Our mission and vision
We aim to champion affordable and accessible healthcare by promoting the use of quality, safe and effective generic and biosimilar medicines and supporting the development of the South African pharmaceutical industry as a national asset.
We are willing to play our part in assisting to improve the efficiency of the regulatory system which will in turn help speed up the registration of generic drugs and lead to further access by patients.
Our Objectives
To promote the use and development of Generic and Biosimilar medicines
Support our membership in creating improved access to medicines
Develop the local pharmaceutical industry as a whole
To participate in policy advisory forums
Sub-committees
Scientific/Biosimilars
Pricing/ Market Access
Trade and Industry/ Tenders
Intellectual Property
Complementary Medicines
Marketing